Upload Avatar (500 x 500)
Lu Wei
wlu@fudan.edu.cn
Chinese, English
Shanghai
Fudan University
Pharmaceutical Sciences
  • 2005 Ph.D. in Pharmaceutics: Fudan University
  • 2000 Bachelor's in Pharmacy: Fudan University
  • 2015 - Present: Professor, School of Pharmacy, Fudan University; PI, State Key Laboratory of Molecular Engineering of Polymers
  • 2010 - 2015: Assistant Professor, Associate Professor (Tenured), College of Pharmacy, University of Rhode Island, USA
  • 2009 - 2010: Lecturer, MD Anderson Cancer Center, University of Texas, USA
  • 2006 - 2009: Postdoctoral Fellow (Molecular Imaging), MD Anderson Cancer Center, University of Texas, USA
  • 2005 - 2006: Lecturer, School of Pharmacy, Fudan University
  • 2007: National Excellent Doctoral Dissertation
  • 2015: Young Pharmaceutics Award, China Pharmaceutical Preparation Conference
  • 2011: First Prize in Natural Science, Ministry of Education (4th place)
  • 2010: Second Prize in Natural Science, Shanghai (4th place)
  • 2007: Second Prize in Science and Technology, Chinese Pharmaceutical Association (2nd place)
  • 2006: Third Prize in Science and Technology, Chinese Pharmaceutical Association (5th place)
  • 2005: Third Prize in Scientific and Technological Progress, Shanghai (5th place)
  • 2004: First Prize in the 18th Shanghai Excellent Invention Selection (1st place)
Theranostic Formulations
Drug Delivery in Cancer Radiotherapy, Chemotherapy, and Immunotherapy
New Drug Formulations and Intelligent Delivery
  • Molecular engineering of near-infrared-II photosensitizers with steric-hindrance effect for image-guided cancer photodynamic therapy, Gao S, Yu S, Zhang Y, Wu A, Zhang S, Wei G, Wang H, Xiao Z, Lu W, 2021
  • Highly tumor-specific and long-acting iodine-131 microbeads for enhanced treatment of hepatocellular carcinoma with low-dose radio-chemoembolization, Qian Y, Liu Q, Li P, Han Y, Zhang J, Xu J, Sun J, Wu A, Song S, Lu W, 2021
  • Copper sulfide nanoparticle-redirected macrophages for adoptive transfer therapy of melanoma, Xu J, Zheng B, Zhang S, Liao X, Tong Q, Wei G, Yu S, Chen G, Wu A, Gao S, Qian Y, Xiao Z, Lu W, 2021
  • High affinity of Chlorin e6 to immunoglobulin G for intraoperative fluorescence image-guided cancer photodynamic and checkpoint blockade therapy, Xu J, Yu S, Wang X, Qian Y, Wu W, Zhang S, Zheng B, Wei G, Gao S, Cao Z, Fu W, Xiao Z, Lu W, 2019
  • Bacterium-mimicking vector with enhanced adjuvanticity for cancer immunotherapy and minimized toxicity, Zheng B, Xu J, Chen G, Zhang S, Xiao Z, Lu W, 2019
  • Albumin tailoring fluorescence and photothermal conversion effect of near-infrared-II fluorophore with aggregation-induced emission characteristics, Gao S, Wei G, Zhang S, Zheng B, Xu J, Chen G, Li M, Song S, Fu W, Xiao Z, Lu W, 2019
  • CuS nanoparticles as a photodynamic nanoswitch for abrogating bypass signaling to overcome Gefitinib resistance, Gu X, Qiu Y, Lin M, Cui K, Chen G, Chen Y, Fan C, Zhang Y, Xu L, Chen H, Wan JB, Lu W, Xiao Z, 2019
  • Copper Sulfide Facilitates Hepatobiliary Clearance of Gold Nanoparticles through the Copper-Transporting ATPase ATP7B, Wang X, Guo L, Zhang S, Chen Y, Chen YT, Zheng B, Sun J, Qian Y, Chen Y, Yan B, Lu W, 2019
  • Editorial for Molecular Imaging and Theranostics, Lu W, 2018
  • 131I-Labeled copper sulfide-loaded microspheres to treat hepatic tumors via hepatic artery embolization, Liu Q, Qian Y, Li P, Zhang S, Liu J, Sun X, Fulham M, Feng D, Huang G, Lu W, Song S, 2018
  • Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles, Guo L, Yan DD, Yang D, Li Y, Wang X, Zalewski O, Yan B, Lu W, 2014
  • A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity, Guo L, Panderi I, Yan DD, Szulak K, Li Y, Chen YT, Ma H, Niesen DB, Seeram N, Ahmed A, Yan B, Pantazatos D, Lu W, 2013
  • Hollow copper sulfide nanoparticle-mediated transdermal drug delivery, Ramadan S, Guo L, Li Y, Yan B, Lu W, 2012
Theranostics Formulations Drug Delivery Cancer Radiotherapy Chemotherapy Immunotherapy New Drug Formulations Intelligent Delivery Nanomedicine

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.